Article Versions Notes

Perkins AT, Haslem D, Goldsberry J, Shortt K, Sittig L, Raghunath S, Giauque C, Snow S, Fulde G, Moulton B, et al. Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs. Cancers. 2021; 13(22):5612. https://doi.org/10.3390/cancers13225612

Perkins, Adrienne T., Derrick Haslem, Jessica Goldsberry, Katherine Shortt, Laura Sittig, Sharanya Raghunath, Christopher Giauque, Shawnee Snow, Gail Fulde, Bryce Moulton, and et al. 2021. "Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs" Cancers 13, no. 22: 5612. https://doi.org/10.3390/cancers13225612

Perkins, A. T., Haslem, D., Goldsberry, J., Shortt, K., Sittig, L., Raghunath, S., Giauque, C., Snow, S., Fulde, G., Moulton, B., Jones, D., & Nadauld, L. (2021). Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs. Cancers, 13(22), 5612. https://doi.org/10.3390/cancers13225612